What amount sold does Biomedical Offshore Value Fund, Ltd. report in Form D filings?

The latest linked filings report $772.3M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Biomedical Offshore Value Fund, Ltd.'s most recent SEC filing?

Biomedical Offshore Value Fund, Ltd.'s most recent Form D filing was on 2025-12-17.

How many investors does Biomedical Offshore Value Fund, Ltd. have?

The most recent Form D filing lists 73 investor(s).

Biomedical Offshore Value Fund, Ltd.

CIK: 0001312877·Pooled Investment Fund·GRAND CAYMAN, E9·Corporation

Reported Sold

$772,302,554

Total Filings

Identified Offerings

Last Filed

Dec 17, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

Offering filing timeline

Dec 17, 2025Form D/A — Amendment

Reported sold: $772,302,554 · Target: Indefinite

Rule 506(b)·73 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Dec 18, 2024Form D/A — Amendment

Reported sold: $771,974,062 · Target: Indefinite

Rule 506(b)·92 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Dec 19, 2023Form D/A — Amendment

Reported sold: $756,755,461 · Target: Indefinite

Rule 506(b)·95 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Dec 23, 2022Form D/A — Amendment

Reported sold: $738,303,062 · Target: Indefinite

Rule 506(b)·76 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Dec 20, 2021Form D/A — Amendment

Reported sold: $33,432,887 · Target: Indefinite

Rule 506(b)·27 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Dec 20, 2021Form D/A — Amendment

Reported sold: $665,384,399 · Target: Indefinite

Rule 506(b)·27 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold

Dec 17, 2020Form D/A — Amendment

Reported sold: $631,951,512 · Target: Indefinite

Rule 506(b)·53 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Feb 27, 2019Form D — New notice

Reported sold: $3,616,165 · Target: Indefinite

Rule 506(b)·2 investors·Section 3(c), Section 3(c)(1)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

—

Reported commissions across identified offerings

Amendment Rate

88%

Latest reported sold across 1 identified offering

$772,302,554

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Jeffrey Jay

Director, Promoter

Appears on 8 filings

-G

-- Great Point Partners, LLC

Promoter

Appears on 6 filings

Alan Kelly

Related Person

Appears on 5 filings

Riyaz Nooruddin

Related Person

Appears on 4 filings

Alan Kelly

Director

Appears on 1 filing

Charl Grobler

Director

Appears on 1 filing

David Kroin

Related Person

Appears on 1 filing

Charl Grobler

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Dec 17, 2025	Amendment	Indefinite	$772,302,554	73
Dec 18, 2024	Amendment	Indefinite	$771,974,062	92
Dec 19, 2023	Amendment	Indefinite	$756,755,461	95
Dec 23, 2022	Amendment	Indefinite	$738,303,062	76
Dec 20, 2021	Amendment	Indefinite	$33,432,887	27
Dec 20, 2021	Amendment	Indefinite	$665,384,399	27
Dec 17, 2020	Amendment	Indefinite	$631,951,512	53
Feb 27, 2019	New	Indefinite	$3,616,165	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Bayview MSR Opportunity Offshore, L.P.

Pooled Investment Fund

Offering target: Indefinite

Filed Oct 29, 2026